Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity (ROP)
This study is enrolling participants by invitation only.
Study NCT00634972   Information provided by University of South Alabama
First Received: March 5, 2008   Last Updated: March 12, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Retinopathy of Prematurity
Retinal Detachment
Blindness
Additional conditions recognized in this trial
Retinal Diseases
More general conditions related to this trial
Eye Diseases
Infant, Newborn, Diseases
Infant, Premature, Diseases
Nervous System Diseases
Neurologic Manifestations
Sensation Disorders
Signs and Symptoms
Vision Disorders
Interventions listed in this trial
ACULAR
REFRESH TEARS
placebo
Additional drug interventions recognized in this trial
Ketorolac
Ketorolac Tromethamine
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of South Alabama


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services